Trial intelligence / Profile preview

Tanakan in Ischemic Stroke Recovery

NCT00276380Phase 3Completed

Sponsor
Ipsen
Start
Feb 2003
Primary completion
Mar 2009
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of ginkgo biloba extract in ischemic stroke, sponsored by Ipsen. Started Feb 2003; status: completed.

02

Drugs

ginkgo biloba extract
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT00276380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00276380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call